Home Suppliers Innoplexus Holdings, Inc.

About

Clinical Research
Product Development
Technology & Operations
Data & Analytics
Employees

Employee
Headquarters

201 Borough High Street, London, SE1-1JA, GBR

Location Map

Innoplexus Holdings, Inc.

Harnessing AI to Accelerate Drug Discovery and Development

Innoplexus is an AI-driven company transforming healthcare through data-powered solutions. Their Augmented Intelligence platform analyzes vast amounts of structured and unstructured data to generate insights that accelerate drug discovery and development across all therapeutic areas and modalities. By leveraging proprietary capabilities in Life Science Language Processing and Computer Vision, Innoplexus uncovers non-obvious connections in multimodal data to reveal the biological complexity underlying diseases. This allows for identification of new therapeutic targets and strategies to enable treatment of previously incurable conditions. With solutions spanning early discovery through commercialization, Innoplexus provides unprecedented causal insights to pharmaceutical companies, biotechs, CROs, hospitals, and academic institutes worldwide. Their comprehensive AI technology aggregates and analyzes over 800 million data points daily, including publications, clinical trials, patents, and more to drive informed decision-making and efficient development of safe and effective therapies for patients.

With over 250 employees and offices in Germany, India, and the US, Innoplexus holds over 120 patent applications in AI, ML, and blockchain. Their interdisciplinary approach and commitment to continuous innovation positions Innoplexus at the forefront in harnessing the power of AI to transform drug development and improve healthcare globally.

Harnessing AI to Accelerate Drug Discovery and Development

Innoplexus is an AI-driven company transforming healthcare through data-powered solutions. Their Augmented Intelligence platform analyzes vast amounts of structured and unstructured data to generate insights that accelerate drug discovery and development across all therapeutic areas and modalities. By leveraging proprietary capabilities in Life Science Language Processing and Computer Vision, Innoplexus uncovers non-obvious connections in multimodal data to reveal the biological complexity underlying diseases. This allows for identification of new therapeutic targets and strategies to enable treatment of previously incurable conditions. With solutions spanning early discovery through commercialization, Innoplexus provides unprecedented causal insights to pharmaceutical companies, biotechs, CROs, hospitals, and academic institutes worldwide. Their comprehensive AI technology aggregates and analyzes over 800 million data points daily, including publications, clinical trials, patents, and more to drive informed decision-making and efficient development of safe and effective therapies for patients.

With over 250 employees and offices in Germany, India, and the US, Innoplexus holds over 120 patent applications in AI, ML, and blockchain. Their interdisciplinary approach and commitment to continuous innovation positions Innoplexus at the forefront in harnessing the power of AI to transform drug development and improve healthcare globally.

Show More

Locations (1)

Location Map

201 Borough High Street, London, SE1-1JA, GBR